Testing effectiveness (Phase 2)UnknownNCT01886976What this trial is testingTreatment of Chemotherapy Refractory Multiple Myeloma by CART-138Who this might be right forMultiple Myeloma Chinese PLA General Hospital 10
Testing effectiveness (Phase 2)Ended earlyNCT00082017What this trial is testingUCN-01 (7-Hydroxystaurosporine) to Treat Relapsed T-Cell LymphomasWho this might be right forLymphoma, Large-Cell, Ki-1Lymphoma, T-Cell National Cancer Institute (NCI) 20
Very early researchWithdrawnNCT07196111What this trial is testingBAFFR CAR-T Treatment for Relapsed/Refractory B-cell TumorsWho this might be right forB Acute Lymphoblastic Leukemia/Lymphoma Guangzhou Bio-gene Technology Co., Ltd
Testing effectiveness (Phase 2)Looking for participantsNCT07013565What this trial is testingChemoimmunotherapy for ALK+ Relapsed/Refractory ALCLWho this might be right forAnaplastic Large Cell Lymphoma, ALK-Positive New York Medical College 20
Very early researchLooking for participantsNCT06684639What this trial is testingA Study on the Efficacy of GD2-CAR T Cells in the Treatment of NeuroblastomaWho this might be right forNeuroblastoma The General Hospital of Western Theater Command 30
Testing effectiveness (Phase 2)Study completedNCT04205409What this trial is testingNivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic MalignanciesWho this might be right forRecurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell LymphomaRecurrent Follicular Lymphoma+15 more University of Washington 20
Early research (Phase 1)UnknownNCT03751293What this trial is testingBCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple MyelomaWho this might be right forRelapsed or Refractory Multiple Myeloma Hebei Yanda Ludaopei Hospital 10
Early research (Phase 1)Temporarily pausedNCT07388563What this trial is testingAzacitidine and Abatacept in Relapsed or Refractory T-Cell LymphomaWho this might be right forLymphoma, T Cell, PeripheralT-cell LymphomaAngioimmunoblastic T-cell Lymphoma+3 more National Cancer Institute (NCI) 20
Very early researchUnknownNCT04028440What this trial is testingΓδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)Who this might be right forNon-Hodgkin's LymphomaRelapsed or Refractory B Cell Non-Hodgkin's LymphomaChronic Lymphoblastic Leukemia+1 more Institute of Hematology & Blood Diseases Hospital, China 6
Not applicableStudy completedNCT00890435What this trial is testingDecision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical TrialWho this might be right forBrain and Central Nervous System TumorsLeukemiaUnspecified Adult Solid Tumor, Protocol Specific+1 more Children's Oncology Group 53
Not applicableNot Yet RecruitingNCT07376720What this trial is testingA Clinical Study Evaluating the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Three or More Lines of TreatmentWho this might be right forMultiple Myeloma Donghua Zhang 28
Testing effectiveness (Phase 2)UnknownNCT01016990What this trial is testingValproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaLymphoma Auxilio Mutuo Cancer Center 52
Early research (Phase 1)Looking for participantsNCT05098613What this trial is testingPreliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL PatientsWho this might be right forNon-Hodgkin LymphomaB-cell Non-Hodgkin Lymphoma (B-NHL)Mantle Cell Lymphoma (MCL)+1 more University of Colorado, Denver 68
Testing effectiveness (Phase 2)Looking for participantsNCT05326243What this trial is testingPhase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell LymphomaWho this might be right forDiffuse Large B Cell LymphomaPrimary Mediastinal Large B Cell LymphomaLarge B-cell Lymphoma+2 more Pell Bio-Med Technology Co., Ltd. 49
Testing effectiveness (Phase 2)Looking for participantsNCT05667506What this trial is testingCNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)Who this might be right forB-cell Acute Lymphoblastic Leukemia Juventas Cell Therapy Ltd. 47
Early research (Phase 1)Study completedNCT00015925What this trial is testingMS-275 in Treating Patients With Hematologic CancerWho this might be right forLeukemiaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes+1 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Looking for participantsNCT06080191What this trial is testingAllogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALLWho this might be right forB-cell Acute Lymphoblastic Leukemia Bambino Gesù Hospital and Research Institute 24
Early research (Phase 1)Looking for participantsNCT03721068What this trial is testingStudy of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory OsteosarcomaWho this might be right forNeuroblastomaOsteosarcoma UNC Lineberger Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)UnknownNCT02495415What this trial is testingTrial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell LymphomasWho this might be right forPeripheral T-cell Lymphoma CerRx, Inc. 140
Testing effectiveness (Phase 2)Looking for participantsNCT05826535What this trial is testingStudy of Rondecabtagene Autoleucel in Aggressive Large B-Cell LymphomaWho this might be right forRelapsed Non-Hodgkin LymphomaRefractory Non-Hodgkin LymphomaNon-Hodgkin Lymphoma+1 more Lyell Immunopharma, Inc. 270